Laboratory Diagnosis of Four Recent Sporadic Cases of Community-acquired SARS, Guangdong Province, China
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Four cases of severe acute respiratory syndrome (SARS) that occurred from December 16, 200316, , to January 8, 2004, in the city of Guangzhou, Guangdong Province, China, were investigated.Clinical specimens collected from these patients were tested by provincial and national laboratories in China as well as members of the World Health Organization SARS Reference and Verification Laboratory Network in a collaborative effort to identify and confirm SARS-associated coronavirus (SARS-CoV) infection.Although SARS-CoV was not isolated from any patient, specimens from three patients were positive for viral RNA by reverse transcription-polymerase chain reaction assay and all patients had detectable rises in SARS-CoV-specific antibodies.This study shows the effectiveness of a collaborative, multilaboratory response to diagnose SARS.I n November 2002, cases of a highly contagious and severe atypical pneumonia were identified in Guangdong Province in southern China (1).By March 2003, the infection had spread to Hong Kong, Singapore, Vietnam, Taiwan, Canada, and the United States.Designated severe acute respiratory syndrome (SARS), the outbreak was subsequently linked to infection with a previously unrecognized coronavirus (SARS-CoV) (2-4).The outbreak ended with the World Health Organization (WHO) announcement on July 5, 2003, that the last patient had recovered and the human chain of SARS transmission was broken (5).In all, 29 countries reported to WHO >8,000 SARS cases with 774 deaths (6).Since WHO's declaration of the end of the SARS epidemic, 17 cases of laboratory-confirmed SARS-CoV infection have been reported.Infections in 13 patients were associated with laboratories: 6 exposed while working in the laboratory and 7 contacts of a patient with a laboratory-acquired case (7-9).The other four cases were acquired in the community.On December 26, the Chinese Ministry of Health informed WHO of the first case of community-acquired SARS in Guangzhou, the capital city
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Self-citationSuperspreading SARS events, Beijing, 2003
Shen, Z., Ning, F., Zhou, W., He, X., Lin, C., Chin, D. P., Zhu, Z., & Schuchat, A. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030732 · Cited by 280
Cited by
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341
“It briefly re-emerged in 2003-2004, with 4 72 confirmed cases of mild human infections and no human-to-human transmission (5-7).”
BackgroundThe spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192
Severe acute respiratory syndrome
Peiris, J. S. M., Guan, Y., & Yuen, K. Y. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,139
Self-citationReceptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S., Huang, I., Xu, K., Vasilieva, N., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600640 · Cited by 988
Graham, R. L., & Baric, R. S. (2010) · Journal of Virology · doi:10.1128/jvi.01394-09 · Cited by 751
Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human
Song, H.-D., Tu, C.-C., Zhang, G.-W., Wang, S.-Y., Zheng, K., Lei, L.-C., Chen, Q.-X., Gao, Y.-W., Zhou, H.-Q., Xiang, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409608102 · Cited by 701
Self-citationter Meulen, J., van den Brink, E. N., Poon, L. L. M., Marissen, W. E., Leung, C. S. W., Cox, F., Cheung, C. Y., Bakker, A. Q., Bogaards, J. A., van Deventer, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030237 · Cited by 612
Self-citationWang, L.-F., Shi, Z., Zhang, S., Field, H., Daszak, P., & Eaton, B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1212.060401 · Cited by 471
“In late 2003 and early 2004, sporadic outbreaks were reported in the region of the People’s Republic of China where the 2002–2003 outbreaks originated (2).”
BackgroundInfluentialThe emerging role of ACE2 in physiology and disease
Hamming, I., Cooper, M., Haagmans, B., Hooper, N., Korstanje, R., Osterhaus, A., Timens, W., Turner, A., Navis, G., & van Goor, H. (2007) · The Journal of Pathology · doi:10.1002/path.2162 · Cited by 434
A review of studies on animal reservoirs of the SARS coronavirus
Shi, Z., & Hu, Z. (2008) · Virus Research · doi:10.1016/j.virusres.2007.03.012 · Cited by 400
Drexler, J. F., Gloza-Rausch, F., Glende, J., Corman, V. M., Muth, D., Goettsche, M., Seebens, A., Niedrig, M., Pfefferle, S., Yordanov, S., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00650-10 · Cited by 392
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
Hilgenfeld, R., & Peiris, M. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.015 · Cited by 354
Kan, B., Wang, M., Jing, H., Xu, H., Jiang, X., Yan, M., Liang, W., Zheng, H., Wan, K., Liu, Q., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11892-11900.2005 · Cited by 346
Self-citationPotent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhu, Z., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X., Hensley, L. E., Prabakaran, P., Rockx, B., Sidorov, I. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701000104 · Cited by 287
Li, W., Wong, S.-K., Li, F., Kuhn, J. H., Huang, I.-C., Choe, H., & Farzan, M. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4211-4219.2006 · Cited by 276
Bats, Civets and the Emergence of SARS
Wang, L. F., & Eaton, B. T. (2007) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-70962-6_13 · Cited by 271
Receptor recognition and cross-species infections of SARS coronavirus
Li, F. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.014 · Cited by 268
He, Y., Li, J., Heck, S., Lustigman, S., & Jiang, S. (2006) · Journal of Virology · doi:10.1128/jvi.00083-06 · Cited by 135
“After the outbreak was contained, several isolated infections were reported during 2003 to 2004 in the Guangzhou region of China, which caused much less severe symptoms (35, 40, 44).”
Background
Metadata
- Authors
- Liang, G., Chen, Q., Xu, J., Liu, Y., Lim, W., Peiris, J. S. M., Anderson, L. J., Ruan, L., Li, H., Kan, B., Di, B., Cheng, P., Chan, K. H., Erdman, D. D., Gu, S., Yan, X., Liang, W., Zhou, D., Haynes, L., Duan, S., Zhang, X., Zheng, H., Gao, Y., Tong, S., Li, D., Fang, L., Qin, P., Xu, W., & SARS Diagnosis Working Group
- Venue
- Emerging Infectious Diseases
- Published
- 2004-10
- Volume
- 10
- Issue
- 10
- Pages
- 1774-1781
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2064822333
- Cited by
- 136
- References
- 3
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.